Building upon prior evidence that pathological tau activates PERK (a kinase promoting translational repression70), a PERK inhibitor was administered to tau transgenic mice, which protected the brains from the deleterious effects of tauopathies.71 This evidence concerns the gene MAPT and tauopathy.